Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Mesoblast Limited ( (AU:MSB) ) has issued an announcement.
JPMorgan Chase & Co. and its affiliates have become a substantial holder in Mesoblast Limited, acquiring a 5.35% voting power in the company as of July 2, 2025. This acquisition involves various subsidiaries of JPMorgan holding significant numbers of ordinary shares through different capacities such as securities lending and proprietary trading, potentially impacting Mesoblast’s shareholder structure and market dynamics.
The most recent analyst rating on (AU:MSB) stock is a Buy with a A$1.10 price target. To see the full list of analyst forecasts on Mesoblast Limited stock, see the AU:MSB Stock Forecast page.
More about Mesoblast Limited
YTD Price Performance: -47.42%
Average Trading Volume: 5,931,230
Technical Sentiment Signal: Hold
Current Market Cap: A$2.08B
For detailed information about MSB stock, go to TipRanks’ Stock Analysis page.